Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Effects of Normobaric Hypoxia Exercise Program on Bone Turnover Markers and Metabolism in Premenopausal Women

NCT06226168 · tracked via the Priya Life Science Poland tracker
Phase
Not applicable
Started
2024-05-07
Last updated
2024-05-08

Condition(s) studied

Hypoxia

Investigational drug(s) / intervention(s)

exercise and environmental conditionsexercise and environmental conditions

exercise and environmental conditions: Participants will perform endurance-strength training for 4 weeks in a variety of environmental conditions. Somatic indices and quantitative indicators of bone mass (bone mineral density) will be measured both before and after the training period. Before the first training day and the day after the last training day, blood will be drawn for biochemical analysis.

exercise and environmental conditions: Passive exposure to normobaric hypoxia conditions. No training intervention. There will be a measurement of selected somatic indices and a quantitative measurement of bone mass indices (bone mineral density). A blood draw for biochemical analysis will be performed.

Study summary

The impact of a proprietary training program in normobaric hypoxia on changes in bone turnover markers as well as carbohydrate and lipid metabolism in premenopausal women falls within the realm of physical culture for an active and healthy society. Within this context, the implementation of a project is supported aiming to:

1. Monitor, support, and promote physical development, fitness, and physical activity in society, by assessing the effects of a proprietary training program in normobaric hypoxia on changes in bone turnover markers as well as carbohydrate and lipid metabolism in premenopausal women.
2. Develop and implement innovative methods, forms, and means of physical activation and training for individuals of various ages, by formulating general assumptions of an endurance-strength training concept under normobaric hypoxia conditions, concerning changes in bone turnover markers as well as carbohydrate and lipid metabolism in premenopausal women.
3. Prevent injuries in physical education and sports, by designing a useful training program for osteoporosis prevention as well as for managing carbohydrate and lipid metabolism disorders in premenopausal women.

Eligibility

Sex
FEMALE
Min age
50 Years
Max age
59 Years
Healthy volunteers
Accepted
Inclusion Criteria: * No significant cardiovascular, respiratory system diseases and musculoskeletal system, * No contraindications to physical activity. ECG, baseline urinalysis, morphology are required. * T-score within normal limits (+1.0 to -1.0). * Informed consent of the patient to participate in the study. Exclusion Criteria: * Use of hormone replacement therapy (HRT). * Use of substances (cigarettes, alcohol). * Any training (including hypoxia training or exposure) performed in the 6 months prior to the beginning of the intervention * Any other factors determined by the study investigators as unsuitable for participation.

Primary outcome measure(s)

  • Blood analysis- part 1 — Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
    Bone turnover markers: bone-specific alkaline phosphatase (ng/ml), osteocalcin (ng/ml), N-terminal telopeptide of type I collagen (ng/ml), osteoprotegerin (ng/ml), 25-hydroxyvitamin D3 metabolite (ng/ml).
  • Blood analysis- part 2 — Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
    Hormones of lipid metabolism: adiponectin (μg/mL)
  • Blood analysis- part 3 — Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
    Hormones of lipid metabolism: lipid profile (mg/dL)
  • Blood analysis- part 4 — Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
    Hormones of lipid metabolism: lipoprotein atherogenicity index (no unit)
  • Blood analysis- part 5 — Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
    Hormones of carbohydrate metabolism: glucose (mg/dL)
  • Blood analysis- part 6 — Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
    Hormones of carbohydrate metabolism: insulin (IU/mL), leptin (IU/mL), ghrelin (IU/mL)
  • Blood analysis- part 7 — Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
    Thyroid hormones: Thyroid Stimulating Hormone (IU/L)
  • Blood analysis- part 8 — Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
    Vitamins: Vitamin D (ng/mL)
  • Blood analysis- part 9 — Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
    Plasma volume changes (ml/kg)
  • Blood analysis- part 10 — Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
    Rheology: viscosity (Pa·s), viscoelasticity (Pa·s)
  • Blood analysis- part 11 — Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
    Rheology: shear rate (s-¹)
  • Blood analysis- part 12 — Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
    Rheology: shear stress (Pa), elastic modulus (Pa)
  • Blood analysis- part 13 — Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
    Blood biochemistry: erythrocytes (million/μL)
  • Blood analysis- part 14 — Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
    Blood biochemistry: leukocytes (thousand/μL), platelets (thousand/μL)
  • Blood analysis- part 15 — Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
    Blood biochemistry: hemoglobin (g/dL)
  • Blood analysis- part 16 — Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
    Blood biochemistry: hematocrit (%), red cell distribution width (%)
  • Blood analysis- part 17 — Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
    Blood biochemistry: mean corpuscular volume (femtoliter)
  • Blood analysis- part 18 — Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
    Blood biochemistry: mean corpuscular hemoglobin (picogram)
  • Blood analysis- part 19 — Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
    Blood biochemistry: mean corpuscular hemoglobin concentration (g/dL), albumin (g/dL)
  • Blood analysis- part 20 — Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
    Blood biochemistry: creatinine (mg/dL), bilirubin (mg/dL), blood urea nitrogen (mg/dL)
  • Blood analysis- part 21 — Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
    Blood biochemistry: erythrocyte sedimentation rate (mm/h)
  • Blood analysis- part 22 — Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
    Blood biochemistry: alanine aminotransferase (U/L), aspartate aminotransferase (U/L)
  • Blood analysis- part 23 — Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts
    Blood biochemistry: ferritin (ng/mL)
  • Bone mass- part 1 — 1 day before and 1 day after the training program. Training will last 4 weeks.
    To identify quantitative indicators of bone mass, a densitometric study will be performed using dual energy X-ray absorptiometry (DXA). Selected quantitative indicators of bone mass will be measured: bone mineral density (g/cm\^2).
  • Bone mass- part 2 — 1 day before and 1 day after the training program. Training will last 4 weeks.
    To identify quantitative indicators of bone mass, a densitometric study will be performed using dual energy X-ray absorptiometry (DXA). Selected quantitative indicators of bone mass will be measured: T-score (no unit).
  • Bone mass- part 3 — 1 day before and 1 day after the training program. Training will last 4 weeks.
    To identify quantitative indicators of bone mass, a densitometric study will be performed using dual energy X-ray absorptiometry (DXA). Selected quantitative indicators of bone mass will be measured: Z-score (no unit).
  • Bone mass- part 4 — 1 day before and 1 day after the training program. Training will last 4 weeks.
    To identify quantitative indicators of bone mass, a densitometric study will be performed using dual energy X-ray absorptiometry (DXA). Selected quantitative indicators of bone mass will be measured: relative skeletal-muscular index (kg/m\^2).
  • Somatic indicators- part 1 — 1 day before and 1 day after the training program. Training will last 4 weeks.
    A densitometry study using dual energy X-ray absorptiometry (DXA) will be conducted to determine body composition: lean body mass (kg).
  • Somatic indicators- part 2 — 1 day before and 1 day after the training program. Training will last 4 weeks.
    A densitometry study using dual energy X-ray absorptiometry (DXA) will be conducted to determine body composition: percentage of body fat (%).
  • Somatic indicators- part 3 — 1 day before and 1 day after the training program. Training will last 4 weeks
    A densitometry study using dual energy X-ray absorptiometry (DXA) will be conducted to determine body composition: fat mass (kg).

Trial sites (2)

FacilityCityRegionStatus
University School of Physical Education in Cracow Krakow Poland Not Yet Recruiting
University School of Physical Education in Cracow Krakow Poland Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06226168 on ClinicalTrials.gov ↗ ← All trials in Poland